LB
33
2
PPL
57
2
STX
64
-5
LRCX
64
2
TAP
37
8
PH
64
2
KMX
38
-9
CF
41
-7
ADI
73
2
BF.B
39
-3
SE
54
5
KMI
63
10
APD
50
5
CNP
52
3
MDLZ
26
-2
PFE
45
12
WEC
45
2
AVGO
35
-19
ROP
42
4
SLG
37
6
LB
33
2
PPL
57
2
STX
64
-5
LRCX
64
2
TAP
37
8
PH
64
2
KMX
38
-9
CF
41
-7
ADI
73
2
BF.B
39
-3
SE
54
5
KMI
63
10
APD
50
5
CNP
52
3
MDLZ
26
-2
PFE
45
12
WEC
45
2
AVGO
35
-19
ROP
42
4
SLG
37
6
Financhill
Back

ProShares UltraShort Consumer Discretionary Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Sell
9

SCC
ProShares UltraShort Consumer Discretionary

Last Price:
$13.79
Seasonality Move:
-3.14%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$31.98
Seasonality Move:
-10.99%
Sell
9
ProShares UltraShort Consumer Discretionary (SCC) is a Sell

Is ProShares UltraShort Consumer Discretionary a Buy, Sell or Hold?

  • The current ProShares UltraShort Consumer Discretionary [SCC] share price is $13.81. The Score for SCC is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • SCC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SCC Stock Price Chart

What is ProShares UltraShort Consumer Discretionary's stock price today?

  • The ProShares UltraShort Consumer Discretionary share price today is $13.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SCC is experiencing buying pressure, which is a positive indicator for future bullish movement.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

SCC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.1 Buy
Relative Strength Index (14 RSI): 38.26 Sell
Chaikin Money Flow: 10367 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.01 - 15.75) Sell
Bollinger Bands (100): (14.27 - 16.01) Sell

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

SCC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.04 Sell
20-day SMA: 14.52 Sell
50-day SMA: 14.83 Sell
200-day SMA: 17.75 Sell
8-day EMA: 8.83 Buy
20-day EMA: 4.6 Buy
50-day EMA: 2.06 Buy
200-day EMA: 0.55 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

ProShares UltraShort Consumer Discretionary Earnings Growth & SCC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

ProShares UltraShort Consumer Discretionary Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):